Mar Domingo Selected Research

Drug Therapy (Chemotherapy)

3/2016

[Baseline characteristics and changes in treatment after a period of optimization of the patients included in the study EFICAR].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mar Domingo Research Topics

Disease

29	Heart Failure 11/2023 - 11/2007
7	Inflammation (Inflammations) 10/2022 - 04/2015
3	Fibrosis (Cirrhosis) 01/2023 - 01/2018
2	Disease Progression 01/2023 - 11/2016
2	Neoplasms (Cancer) 08/2020 - 01/2020
2	Chronic Renal Insufficiency 11/2014 - 03/2014
1	Type 2 Diabetes Mellitus (MODY) 03/2023
1	Atherosclerosis 01/2023
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023
1	Pulmonary Hypertension 01/2022
1	Iron Deficiencies 01/2022
1	Obesity 01/2022
1	Hypertrophy 01/2021
1	COVID-19 12/2020
1	Interatrial Block 11/2018
1	ST Elevation Myocardial Infarction 01/2018
1	Heart Diseases (Heart Disease) 12/2017
1	Atrial Fibrillation 12/2017
1	Cognitive Dysfunction 11/2017
1	Anemia 09/2016
1	Systolic Heart Failure 04/2015
1	Bundle-Branch Block (Fascicular Block) 04/2015
1	Necrosis 04/2015
1	Brain Infarction 10/2013
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 10/2013
1	Hypertension (High Blood Pressure) 11/2007

Drug/Important Bio-Agent (IBA)

11	Biomarkers (Surrogate Marker)IBA 01/2023 - 04/2015
6	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2023 - 07/2012
6	pro-brain natriuretic peptide (1-76)IBA 01/2023 - 07/2012
6	Neprilysin (Neutral Endopeptidase)IBA 01/2022 - 02/2015
5	Troponin T (Troponin T1)IBA 01/2023 - 04/2015
3	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 11/2023 - 12/2017
3	Galectin 3 (LGALS3)IBA 04/2015 - 11/2014
3	CreatinineIBA 03/2014 - 11/2007
2	Peptides (Polypeptides)IBA 01/2023 - 11/2017
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2022 - 02/2015
2	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2022 - 01/2021
2	C-Reactive ProteinIBA 01/2020 - 04/2015
2	Hemoglobins (Hemoglobin)IBA 09/2016 - 11/2007
2	Cystatin CIBA 11/2014 - 03/2014
1	Fatty Acid-Binding ProteinsIBA 03/2023
1	TroponinIBA 01/2023
1	Procollagen Type IIBA 01/2023
1	Trinitrotoluene (TNT)IBA 01/2023
1	Collagen Type I (Type I Collagen)IBA 01/2023
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 01/2023
1	Proprotein Convertase 9IBA 01/2023
1	evolocumabIBA 01/2023
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023
1	procollagen type I carboxy terminal peptide (PICP)IBA 01/2023
1	LDL CholesterolIBA 01/2023
1	dapagliflozinIBA 01/2023
1	oxidized low density lipoproteinIBA 01/2023
1	Protons (Proton)IBA 10/2022
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 10/2022
1	AcetylglucosamineIBA 10/2022
1	GalactosamineIBA 10/2022
1	SymportersIBA 01/2021
1	SodiumIBA 01/2021
1	empagliflozinIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	AntigensIBA 01/2020
1	InterleukinsIBA 01/2020
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2020
1	AnticoagulantsIBA 11/2018
1	BenzodiazepinesIBA 01/2018
1	Angiotensin Receptor AntagonistsIBA 01/2018
1	Amyloid beta-PeptidesIBA 11/2017
1	Enalapril FDA LinkGeneric 02/2015
1	IsotopesIBA 03/2014
1	AlbuminsIBA 10/2013
1	Natriuretic PeptidesIBA 07/2012

Therapy/Procedure

3	Therapeutics 01/2023 - 03/2016
1	Ambulatory Care (Outpatient Care) 12/2020
1	Palliative Care (Palliative Therapy) 10/2019
1	Patient Readmission 01/2018
1	Stents 01/2018
1	Percutaneous Coronary Intervention 01/2018
1	Drug Therapy (Chemotherapy) 03/2016